Kidney Stone Management Devices Market Insights on Primary Trends by 2028
Posted by Arslan on February 11th, 2019
Seamless and safe removal of large kidney stones continues to be a focus area for healthcare providers. The evolving demand has catalyzed the initiatives taken by medical device manufacturers to launch innovative equipment in the market. For instance, Cogentix Medical’s launched the XenX® Stone Management Device to remove kidney stone fragments larger than 1mm. SonoMotion, another key player in the kidney stone management devices market, is reinvigorating its non-invasive solutions for kidney stone disease through launch of Break Wave. In a bid to cater to the imminent need for removing large kidney stones safely and effectively, industry-institution collaboration is also gaining ground – the development of PAKAD by Institute of Technical Education (ITE) at Singapore and HCMT Holdings Pte Ltd (HCMT) is a case in point. Sensing the evolving demands in the kidney stone management devices market, it is highly likely that industry-institution collaboration for treating large kidney stones will gain momentum.
High cost and fragility of reusable ureteroscopes continues to induce a preference for single-use, disposable scopes. Challenges on account of unavailability of ureteroscopes can be mitigated through the use of single-use and disposable scopes. However, concerns pertaining to deflection and irrigation flow have led to the limited adoption of single-scope and disposable scopes. Researchers have been working on comparing the performance of disposable scopes with reusable scopes, and a new study can have a significant impact on the sales of the former. According to researchers DB Hennessey, G Fojecki, N Papa, N Lawrentschuk, D Bolton found that “The LithoVue is analogous to reusable flexible ureteroscopes in regard to standard technical metrics. Depending on its purchase cost it may also represent a cost saving for hospitals when compared to the cumulative costs of maintaining reusable scopes. Additionally, urologist may consider using the scope in cases in which reusable scope damage is anticipated.”
Rising preference for minimally invasive methodologies is driving the adoption of percutaneous nephrolithotomy (PCNL). Less postoperative pain and minimum complications are among the key factors driving adoption of PCNL, especially for treatment of large kidney stones. Additionally, favorable reimbursement policies are also enhancing their penetration across various regions. Driven by superior post-treatment stone-free rates, PCNL presents a wide array of avenues for manufacturers to explore. Moreover, technological advancements such as patient positioning, miniaturized access tracts, development of lithotriptors, and postoperative nephrostomy tube management are fueling adoption of PCNL devices.
The competency of a kidney stone management device is no longer limited to treatment of kidney stones, there is more to it than that. Shock wave kidney management provides effective remedies for musculoskeletal disorders such as heel spurs, epicondylitis and plantar fasciitis. Moreover, kidney stone management devices are also being employed in a wide array of applications, ranging from experimental bactericidal to cardiac treatments. Applications of kidney stone management devices across diverse applications are foreseen to offer niche and untapped opportunities for the manufacturers to explore.
Installation rates of kidney stone management devices across hospitals are poised to remain considerably higher than other end users. According to a recent journal published in NCBI, kidney stone affects 1 in 11 people in the U.S. The journal further finds that on an average of 600,000 Americans suffer from urinary stones every year. The journal also unveils that around 12% of the Indian population is diagnosed with urinary stones. Thus, hospitals will continue to stay at the forefront of demand for kidney stone management devices over the forecast timeline. However, the growth prospects of specialty clinics remain bullish at an impressive CAGR for the forecast period of 2018-2028.
The report on kidney stone management devices market features prominent players having exclusive foothold in the industry. After a comprehensive value chain analysis of the kidney stone management devices market, the report features key players operating in the kidney stone management devices market including Siemens Healthineers AG, Dornier MedTech (Subsidiary of Accuron MedTech), Lumenis Ltd., STORZ MEDICAL AG, Inceler Medikal Co. Ltd., DirexGroup, Medispec Ltd., EDAP TMS S.A., GEMSS Co., Ltd. and Richard Wolf GmbH. Industry participants of the kidney stone management devices market are executing individual strategies with regard to product offerings and developments, launching new manufacturing facilities, and consolidation practices.Top Searches - Trending Searches - New Articles - Top Articles - Trending Articles - Featured Articles - Top Members
Copyright © 2020 Uberant.com706,282 total articles and counting.